Literature DB >> 16801035

Clinical features of Ehlers-Danlos syndrome.

Jui-Lung Yen1, Shuan-Pei Lin, Ming-Ren Chen, Dau-Ming Niu.   

Abstract

BACKGROUND/
PURPOSE: Ehlers-Danlos syndrome (EDS) is a clinically and genetically heterogeneous connective tissue disorder characterized by hyperextensibility of the skin, hypermobility of joints, and tissue fragility. This retrospective study analyzed the characteristics of patients with EDS.
METHODS: Review of medical records identified 16 cases of EDS during the study period from November 1997 to October 2002. Data on these patients, including clinical presentation, physical examinations, Beighton score, echocardiogram, bone mineral density findings and clinical classification, were analyzed.
RESULTS: The age of the patients ranged from 13 months to 36 years. All patients had skin hyperextensibility, joint hypermobility (Beighton score > 5 points), and tissue fragility. Complete bone mineral density study was performed in 11 patients and revealed that all had osteoporosis. Echocardiographic study was performed in 14 patients and showed aortic root dilatation/valve prolapse in 6/14 (43%). Other common features of EDS had the following prevalence: premature rupture of membranes in 3/16 (19%); prematurity in 3/16 (19%); neonatal hypotonia in 5/16 (31%); congenital hip dislocation in 3/16 (19%); unstable gait in 7/16 (44%); bone fracture(s) in 3/16 (19%); motor delay in 3/16 (19%); scoliosis in 3/16 (19%); short stature in 7/16 (44%); and positive family history in 8/16 (50%). All patients had a Beighton score of more than 5 points.
CONCLUSION: The results of this study emphasize the importance of echocardiographic monitoring of aortic size and valvular condition, and assessment of bone mineral density in patients with EDS. Clinical evaluation and counseling should be undertaken prior to pregnancy in patients with EDS because of the risk from labor and vaginal delivery in patients with type IV and the inability to distinguish EDS subtypes in Taiwan due to the unavailability of biochemical assay or molecular mutation analysis as part of standard care.

Entities:  

Mesh:

Year:  2006        PMID: 16801035     DOI: 10.1016/S0929-6646(09)60187-X

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  23 in total

Review 1.  Bone Disease in Patients with Ehlers-Danlos Syndromes.

Authors:  Shuaa Basalom; Frank Rauch
Journal:  Curr Osteoporos Rep       Date:  2020-04       Impact factor: 5.096

2.  Ehlers-Danlos arthrochalasia type (VIIA-B)--expanding the phenotype: from prenatal life through adulthood.

Authors:  M Klaassens; E Reinstein; Y Hilhorst-Hofstee; J J P Schrander; F Malfait; H Staal; L C ten Have; J Blaauw; H C J Roggeveen; D Krakow; A De Paepe; M A M van Steensel; G Pals; J M Graham; C T R M Schrander-Stumpel
Journal:  Clin Genet       Date:  2011-08-24       Impact factor: 4.438

3.  Type III collagen modulates fracture callus bone formation and early remodeling.

Authors:  Emily L Miedel; Becky K Brisson; Todd Hamilton; Hadley Gleason; Gary P Swain; Luke Lopas; Derek Dopkin; Joseph E Perosky; Kenneth M Kozloff; Kurt D Hankenson; Susan W Volk
Journal:  J Orthop Res       Date:  2015-03-08       Impact factor: 3.494

4.  Altered decorin and Smad expression in human fetal membranes in PPROM.

Authors:  Casie E Horgan; Hailey Roumimper; Richard Tucker; Beatrice E Lechner
Journal:  Biol Reprod       Date:  2014-09-17       Impact factor: 4.285

5.  Fracture incidence in Ehlers-Danlos syndrome - A population-based case-control study.

Authors:  Mary C Rolfes; David R Deyle; Katherine S King; Jennifer L Hand; Arne H Graff; Chris Derauf
Journal:  Child Abuse Negl       Date:  2019-03-08

6.  A mouse model of spontaneous preterm birth based on the genetic ablation of biglycan and decorin.

Authors:  Megan L Calmus; Elyse E Macksoud; Richard Tucker; Renato V Iozzo; Beatrice E Lechner
Journal:  Reproduction       Date:  2011-04-18       Impact factor: 3.906

7.  Compensatory fetal membrane mechanisms between biglycan and decorin in inflammation.

Authors:  Luciana Batalha de Miranda de Araujo; Casie E Horgan; Abraham Aron; Renato V Iozzo; Beatrice E Lechner
Journal:  Mol Reprod Dev       Date:  2015-04-23       Impact factor: 2.609

8.  Spontaneous rupture of the spleen in type IV Ehlers-Danlos syndrome: report of a case.

Authors:  Antonio Privitera; Chaz Milkhu; Vivek Datta; Mazim Sayegh; Richard Cohen; Alastair Windsor
Journal:  Surg Today       Date:  2009-01-08       Impact factor: 2.549

9.  MRI of great vessel morphology and function in Ehlers-Danlos syndrome type IV.

Authors:  William Kerwin; Melanie Pepin; Lee Mitsumori; Vasily Yarnykh; Ulrike Schwarze; Peter Byers
Journal:  Int J Cardiovasc Imaging       Date:  2007-11-28       Impact factor: 2.357

10.  Type III collagen regulates osteoblastogenesis and the quantity of trabecular bone.

Authors:  Susan W Volk; Shalin R Shah; Arthur J Cohen; Yanjian Wang; Becky K Brisson; Laurie K Vogel; Kurt D Hankenson; Sherrill L Adams
Journal:  Calcif Tissue Int       Date:  2014-03-14       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.